<DOC>
	<DOCNO>NCT01374178</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics pharmacodynamics LY2963016 compare basal insulin . The study also gather information safety tolerability LY2963016 healthy subject . The study approximately 12 week .</brief_summary>
	<brief_title>A Comparison LY2963016 Basal Insulin After Single Dose Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Are overtly healthy male female Have body mass index ( BMI ) 18.5 29.9 kilogram per square meter ( kg/m^2 ) Are nonsmoker Have normal blood pressure pulse rate Have electrocardiogram ( ECG ) consider within normal limit Have clinical laboratory test result within normal reference range Are currently enrol , discontinue within last 30 day , clinical trial involve investigational drug device Have know allergy insulin excipients Have significant history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder Show evidence significant active neuropsychiatric disease Have history firstdegree relative know diabetes mellitus Have fast venous blood glucose &gt; 6.0 millimoles per liter ( mmol/L ) Intend use overthecounter prescription medication Have donate blood loss 450 milliliter ( mL ) past 3 month Have average weekly alcohol intake exceed 21 unit per week ( male ) 14 unit per week ( female )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>